Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Omega-3 Supplementation Effects on Body Weight and Depression Among Dieter Women With Co-Morbidity of Depression and Obesity Compared With the Placebo: A Randomized Clinical Trial
Amirreza Azimi
Amirreza Azimi

Professor of Multiple Sclerosis and Related Disorders

Department Neurology

School of Medicine

Sina Hospital

Multiple Sclerosis Research Center

Tehran University of Medical Sciences

All Documents
1. Exit Strategy Patterns in Second-Line Therapies for Relapsing Forms of Multiple Sclerosis, Acta Neurologica Belgica (2026)
2. Impact of Vitamin D and Curcumin on Cd4+ and Cd8+ T Cells Expressing Cxcr3, Ccr4, and Ccr6 Chemokine Receptors in Patients With Relapsing-Remitting Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2026)
3. Longitudinal Effects of Dimethyl Fumarate on Patient-Reported Outcome Measures in Multiple Sclerosis: Treatment Satisfaction, Quality of Life, Depressive Symptoms, Sleep, and Work Productivity, Journal of Clinical Neuroscience (2026)
4. Longitudinal Effects of Dimethyl Fumarate on Patient-Reported Outcome Measures in Multiple Sclerosis: Treatment Satisfaction, Quality of Life, Depressive Symptoms, Sleep, and Work Productivity, Journal of Clinical Neuroscience (2026)
5. Post-Infusion Observation of Patients With Multiple Sclerosis Receiving Natalizumab: Is It Necessary?, Multiple Sclerosis and Related Disorders (2026)
6. Quantitative Susceptibility Mapping-Based Characterization of Lesion Heterogeneity in Multiple Sclerosis, Journal of Magnetic Resonance Imaging (2026)
7. Assessment of the Efficacy of Lisdexamfetamine on Fatigue in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study, Multiple Sclerosis and Related Disorders (2025)
8. Depression, Sexual Function and Sexual Quality of Life in Iranian Women With Multiple Sclerosis (Ms), Journal of Obstetrics, Gynecology and Cancer Research (2025)
9. Infections in Patients With Multiple Sclerosis Treated With Disease-Modifying Therapies: A Comparative Risk Assessment Cohort Study, Current Journal of Neurology (2025)
10. Effects of Dry Needling on Gastrocnemius Muscle Spasticity and Gait in Patients With Multiple Sclerosis: A Pilot Randomized Controlled Trial, Medical Acupuncture (2024)
11. Effects of Dry Needling on Gastrocnemius Muscle Spasticity and Gait in Patients With Multiple Sclerosis: A Pilot Randomized Controlled Trial, Medical Acupuncture (2024)
12. The Patient-Reported Outcomes for the New Brand-Generic Teriflunomide in Relapsing-Remitting Multiple Sclerosis, Clinical Neurology and Neurosurgery (2024)
13. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
14. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
15. Cadasil Masquerading As Multiple Sclerosis: A Case Report With Atypical Presentation and Uncharacteristic Neuroimaging Findings; [Cadasil پشت نقاب مالتیپل اسکلروزیس: گسارش مورد], Journal of Isfahan Medical School (2023)
16. Changes in Diffusion Tensor Imaging Indices in Basal Ganglia and Thalamus of Patients With Relapsing-Remitting Multiple Sclerosis and Relation With Clinical Conditions: A Case-Control Study, European Journal of Radiology Open (2023)
17. Economic Burden of Multiple Sclerosis Drugs in Iran During 2011-2019, Iranian Journal of Public Health (2023)
18. Effect of Vitamin a on Recovery From the Acute Phase of Multiple Sclerosis-Related Optic Neuritis, Double-Blind, Randomized, Placebo-Controlled Trial, Caspian Journal of Internal Medicine (2023)
19. Evaluation of Obsessive-Compulsive Disorder Prevalence in Iranian Patients With Multiple Sclerosis and Its Relationship With Demographic Characteristics, Current Journal of Neurology (2023)
20. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
21. Iranian Specialists’ Approach to Surgery in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
22. Iranian Specialists’ Approach to Treatment Escalation in Multiple Sclerosis Patients With Cognitive Impairment, Current Journal of Neurology (2023)
23. Iranian Specialists’ Approach to Treatment Escalation in Multiple Sclerosis Patients With Cognitive Impairment, Current Journal of Neurology (2023)
24. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
25. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
26. The Effect of Body Mass Index on the Morbidity and Outcomes of Covid-19 in Iranian Patients With Multiple Sclerosis, Current Journal of Neurology (2023)
27. Therapeutic Plasma Exchange (Tpe) Complications in Patients With Multiple Sclerosis (Ms) and Clinically Isolated Syndrome (Cis): A Report From a Tertiary Center, Neurologist (2023)
28. Typical Trident Sign and Cardiac Involvement in a Patient Suspected to Sarcoidosis Despite Negative Whole-Body Fdg-Pet: A Case Report, Journal of Medical Case Reports (2023)
29. Adding Erythropoietin to Intravenous Methylprednisolone in Acute Treatment of Attacks of Neuromyelitis Optica Spectrum Disorders: A Randomized Controlled Trial, Current Journal of Neurology (2022)
30. Covid-19 Vaccine Hesitancy in Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
31. Disease-Modifying Therapies and T1 Hypointense Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, CNS Neuroscience and Therapeutics (2022)
32. Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? an Mrs Study in Patients With Ms, American Journal of Neuroradiology (2022)
33. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
34. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
35. Estimation the Medical Cost of Multiple Sclerosis in Iran; 2019–2020, BMC Health Services Research (2022)
36. Evaluation of Liver Injury in Multiple Sclerosis Patients Receiving Pulsed Steroid Therapy, Multiple Sclerosis and Related Disorders (2022)
37. Integrated Cognitive Rehabilitation Home-Based Protocol to Improve Cognitive Functions in Multiple Sclerosis Patients: A Randomized Controlled Study, Journal of Clinical Medicine (2022)
38. Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Series From Iran, Revue Neurologique (2022)
39. Natalizumab-Induced Thrombocytopenia: A Case Report, Current Journal of Neurology (2022)
40. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
41. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
42. The Perspective of Iranian Patients With Multiple Sclerosis on the Third Dose of Covid-19 Vaccine, Current Journal of Neurology (2022)
43. The Study of Covid-19 Infection Following Vaccination in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
44. A Study on the Effects of Dry Needling in Multiple Sclerosis Patients With Spasticity: Protocol of a Randomized Waitlist-Controlled Trial, JAMS Journal of Acupuncture and Meridian Studies (2021)
45. A Study on the Effects of Dry Needling in Multiple Sclerosis Patients With Spasticity: Protocol of a Randomized Waitlist-Controlled Trial, JAMS Journal of Acupuncture and Meridian Studies (2021)
46. Adverse Events Reported by Iranian Patients With Multiple Sclerosis After the First Dose of Sinopharm Bbibp-Corv, Vaccine (2021)
47. Air Pollution and Multiple Sclerosis: A Comprehensive Review, Neurological Sciences (2021)
48. Comparison of Phase-Sensitive Inversion Recovery and Conventional Magnetic Resonance Imaging for Detection of Cortical Plaques in Ms Patients, Iranian Journal of Radiology (2021)
49. Evaluation of the Effect of Multiple Linear Gadolinium-Based Contrast Agent Exposures on the Signal Intensity of the Dentate Nucleus in Multiple Sclerosis Patients, Iranian Journal of Radiology (2021)
50. Neuromyelitis Optica Spectrum Disorder (Nmosd) Associated With Cancer: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)
51. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
52. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
53. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
54. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
55. A Randomized Controlled Trial Investigating the Effects of a Mediterranean-Like Diet in Patients With Multiple Sclerosis-Associated Cognitive Impairments and Fatigue, Current Journal of Neurology (2020)
56. B-Cell Depleting Therapies May Affect Susceptibility to Acute Respiratory Illness Among Patients With Multiple Sclerosis During the Early Covid-19 Epidemic in Iran, Multiple Sclerosis and Related Disorders (2020)
57. Bladder Dysfunction in Iranian Patients With Multiple Sclerosis, Journal of Multidisciplinary Healthcare (2020)
58. Efficacy and Safety of Rituximab in Treating Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2020)
59. Evaluation of Covid-19 Infection in Patients With Neuromyelitis Optica Spectrum Disorder (Nmosd): A Report From Iran, Multiple Sclerosis and Related Disorders (2020)
60. Evaluation of the Rate of Covid-19 Infection, Hospitalization and Death Among Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
61. Incidence of Seroconversion and Sero-Reversion in Patients With Multiple Sclerosis (Ms) Who Had Been Treated With Natalizumab: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2020)
62. Novel Fmri-Compatible Wrist Robotic Device for Brain Activation Assessment During Rehabilitation Exercise, Medical Engineering and Physics (2020)
63. Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients With Multiple Sclerosis, Journal of Multidisciplinary Healthcare (2020)
64. Stressful Life Events, Socioeconomic Status, and the Risk of Neuromyelitis Optica Spectrum Disorder: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2020)
65. Age at Menarche and Risk of Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, BMC Neurology (2019)
66. Autoimmune Diseases Associated With Neuromyelitis Optica Spectrum Disorders: A Literature Review, Multiple Sclerosis and Related Disorders (2019)
67. Comparison of Phase Sensitive Inversion Recovery Mri With T2w-Tse and Stir in the Detection of Cervical Multiple Sclerosis Lesions, Iranian Journal of Radiology (2019)
68. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
69. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
70. Effects of Sensory and Oral- Motor Exercises on Oropharyngeal Dysphagia in Patients With Multiple Sclerosis, Koomesh (2019)
71. The Association Between Dietary Sugar Intake and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Multiple Sclerosis and Related Disorders (2019)
72. The Effect of Traditional Dysphagia Therapy on the Swallowing Function in Patients With Multiple Sclerosis: A Pilot Double-Blinded Randomized Controlled Trial, Journal of Bodywork and Movement Therapies (2019)
73. The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review, JMIR Research Protocols (2019)
74. Α-Lipoic Acid, Functional Fatty Acid, As a Novel Therapeutic Alternative for Central Nervous System Diseases: A Review, Nutritional Neuroscience (2019)
75. Anti-Jc Virus Antibody Sera Positivity and Index Value Among Patients With Multiple Sclerosis May Be Correlated With Age, Sex, and Area of Residence, Journal of NeuroVirology (2018)
76. Association of Nod-Like Receptor Protein-3 Single Nucleotide Gene Polymorphisms and Expression With the Susceptibility to Relapsing–Remitting Multiple Sclerosis, International Journal of Immunogenetics (2018)
77. Environmental Risk Factors in Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Acta Neurologica Belgica (2018)
78. The Prevalence, Incidence and Familial Recurrence of Multiple Sclerosis in Tehran, Iran, Multiple Sclerosis and Related Disorders (2018)
79. Comparing Epidemiology and Baseline Characteristic of Multiple Sclerosis and Neuromyelitis Optica: A Case-Control Study, Multiple Sclerosis and Related Disorders (2017)
80. Cross-Cultural Adaption and Validation of the Persian Version of the Swal-Qol, Medicine (United States) (2017)
81. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
82. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
83. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)
84. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
85. The Expression of Vdr Mrna But Not Nf-Κb Surprisingly Decreased After Vitamin D Treatment in Multiple Sclerosis Patients, Neuroscience Letters (2017)
86. Channelopathy-Related Scn10a Gene Variants Predict Cerebellar Dysfunction in Multiple Sclerosis, Neurology (2016)
87. Coenzyme Q10 As a Treatment for Fatigue and Depression in Multiple Sclerosis Patients: A Double Blind Randomized Clinical Trial, Nutritional Neuroscience (2016)
88. Lipoic Acid Function and Its Safety in Multiple Sclerosis, Probiotics# Prebiotics# and Synbiotics: Bioactive Foods in Health Promotion (2016)
89. Neuromyelitis Optica and Pregnancy, Acta Neurologica Belgica (2016)
90. Personality Characteristics in Ms Patients: The Role of Avoidant Personality, Clinical Neurology and Neurosurgery (2016)
91. Validity and Reliability of the Persian Version of the Perception De La Scle’Rose En Plaques Et De Ses Pousse’Es Questionnaire Evaluating Multiple Sclerosis-Related Quality of Life, International Journal of Preventive Medicine (2016)
92. Classification Algorithms With Multi-Modal Data Fusion Could Accurately Distinguish Neuromyelitis Optica From Multiple Sclerosis, NeuroImage: Clinical (2015)
93. Coenzyme Q10 Supplementation Ameliorates Inflammatory Markers in Patients With Multiple Sclerosis: A Double Blind, Placebo, Controlled Randomized Clinical Trial, Nutritional Neuroscience (2015)
94. The Role of Cerebellar Abnormalities in Neuromyelitis Optica - a Comparison With Multiple Sclerosis and Healthy Controls, Multiple Sclerosis (2015)
95. Vitamin D Supplementation Up-Regulates Il-6 and Il-17A Gene Expression in Multiple Sclerosis Patients, International Immunopharmacology (2015)
96. Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial, NeuroImmunoModulation (2014)